BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29936930)

  • 1. Genomic characterization of clonal evolution during oropharyngeal carcinogenesis driven by human papillomavirus 16.
    Chae J; Park WS; Kim MJ; Jang SS; Hong D; Ryu J; Ryu CH; Kim JH; Choi MK; Cho KH; Moon SH; Yun T; Kim JI; Jung YS
    BMB Rep; 2018 Nov; 51(11):584-589. PubMed ID: 29936930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas.
    Gao G; Wang J; Kasperbauer JL; Tombers NM; Teng F; Gou H; Zhao Y; Bao Z; Smith DI
    BMC Cancer; 2019 Apr; 19(1):352. PubMed ID: 30975103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV+ oropharyngeal squamous cell carcinomas from patients with two tumors display synchrony of viral genomes yet discordant mutational profiles and signatures.
    Faden DL; Langenbucher A; Kuhs K; Lewis JS; Mirabello L; Yeager M; Boland JF; Bass S; Steinberg M; Cullen M; Lawrence MS; Ferris RL
    Carcinogenesis; 2021 Feb; 42(1):14-20. PubMed ID: 33075810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
    Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors.
    Rietbergen MM; Braakhuis BJ; Moukhtari N; Bloemena E; Brink A; Sie D; Ylstra B; Baatenburg de Jong RJ; Snijders PJ; Brakenhoff RH; Leemans CR
    J Oral Pathol Med; 2014 Feb; 43(2):137-42. PubMed ID: 24118314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
    Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
    van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
    Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
    Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
    Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.
    Hatano T; Sano D; Takahashi H; Hyakusoku H; Isono Y; Shimada S; Sawakuma K; Takada K; Oikawa R; Watanabe Y; Yamamoto H; Itoh F; Myers JN; Oridate N
    Int J Cancer; 2017 Apr; 140(7):1571-1580. PubMed ID: 28006857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H
    Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation patterns in recurrent and/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status.
    Reder H; Wagner S; Wuerdemann N; Langer C; Sandmann S; Braeuninger A; Dugas M; Gattenloehner S; Wittekindt C; Klussmann JP
    Cancer Med; 2021 Feb; 10(4):1347-1356. PubMed ID: 33527763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma.
    Carper MB; Troutman S; Wagner BL; Byrd KM; Selitsky SR; Parag-Sharma K; Henry EC; Li W; Parker JS; Montgomery SA; Cleveland JL; Williams SE; Kissil JL; Hayes DN; Amelio AL
    Cell Rep; 2019 Nov; 29(6):1660-1674.e7. PubMed ID: 31693903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
    Hufbauer M; Maltseva M; Meinrath J; Lechner A; Beutner D; Huebbers CU; Akgül B
    Int J Cancer; 2018 Sep; 143(6):1426-1439. PubMed ID: 29663357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8
    Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
    Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
    Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
    Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oropharyngeal HPV Detection Techniques in HPV-associated Head and Neck Cancer Patients.
    Eggersmann TK; Baumeister P; Kumbrink J; Mayr D; Schmoeckel E; Thaler CJ; Dannecker C; Jeschke U; Nagler T; Mahner S; Sharaf K; Gallwas JKS
    Anticancer Res; 2020 Apr; 40(4):2117-2123. PubMed ID: 32234904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma.
    Cerasuolo A; Annunziata C; Tortora M; Starita N; Stellato G; Greggi S; Maglione MG; Ionna F; Losito S; Botti G; Buonaguro L; Buonaguro FM; Tornesello ML
    Oncotarget; 2017 May; 8(21):34070-34081. PubMed ID: 28423662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.